OATP1B1 and DAA Treatment for Hepatitis C in Patients With Hepatocellular Carcinoma REPLY

被引：0
|
作者：
Soria, Alessandro [1 ]
Lapadula, Giuseppe [1 ]
Fabbiani, Massimiliano [1 ]
Gori, Andrea [1 ]
机构：
[1] Univ Milano Bicocca, San Gerardo Hosp, Clin Infect Dis, Monza, Italy
来源：
HEPATOLOGY | 2017年 / 66卷 / 06期
关键词：
IGG; RECEPTOR; FCRN;
D O I：
10.1002/hep.29553
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2091 / 2092
页数：2
相关论文
共 50 条
  • [1] Characteization of OATP1B1 and OATP1B3 inhibition by Nilotinib
    Sprowl, Jason A.
    Chen, Mingqing
    Gibson, Alice A.
    Pasquariello, Kyle Z.
    Sparreboom, Alex
    Hu, Shuiying
    FASEB JOURNAL, 2019, 33
  • [2] Dissecting the Contribution of OATP1B1 to Hepatic Uptake of Statins Using the OATP1B1 Selective Inhibitor Estropipate
    Zhang, Yueping
    Panfen, Erika
    Fancher, Marcus
    Sinz, Michael
    Marathe, Punit
    Shen, Hong
    MOLECULAR PHARMACEUTICS, 2019, 16 (06) : 2342 - 2353
  • [3] FUNCTIONAL ASSESSMENT OF OATP1B1 AND BCRP POLYMORPHISMS IN AN OATP1B1/BCRP CO-EXPRESSING MODEL
    Warren, Mark
    Jahic, Mirza
    Zhang, Xuexiang
    Kaufman, Ilene
    Huang, Jane
    Huang, Yong
    DRUG METABOLISM REVIEWS, 2014, 45 : 246 - 247
  • [4] Dynamic Prediction of the Risk of Hepatocellular Carcinoma After DAA Treatment for Hepatitis C Patients
    Ma, Xinyan
    Huang, Lili
    Yu, Meijie
    Dong, Rui
    Wang, Yifan
    Chen, Hongbo
    Yu, Rongbin
    Huang, Peng
    Wang, Jie
    CANCER CONTROL, 2025, 32
  • [5] Therapeutic Implications of OATP1B1 Polymorphisms
    Niemi, Mikko
    DRUG METABOLISM REVIEWS, 2010, 42 : 7 - 7
  • [6] Effect of statins on OATP1B1 expression
    Duck, Zachary A.
    Wright, Stephen
    Wilkerson, Matt
    Li, Jibin
    Hidalgo, Ismael
    FASEB JOURNAL, 2013, 27
  • [7] Rifampicin Transport by OATP1B1 Variants
    Litjens, Carlijn H. C.
    van den Heuvel, Jeroen J. M. W.
    Russel, Frans G. M.
    Aarnoutse, Rob E.
    te Brake, Lindsey H. M.
    Koenderink, Jan B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (10)
  • [8] Establishing the Competitive Counterflow Assay for OATP1B1 and OATP1B3
    Katuwal, Miki
    Schnegelberger, Regina
    Wityk, Elliott
    Ruggiero, Melissa
    Hagenbuch, Bruno
    FASEB JOURNAL, 2016, 30
  • [9] Effect of OATP1B1 genotypes on plasma concentrations of endogenous OATP1B1 substrates and drugs, and their association in healthy volunteers
    Mori, Daiki
    Kashihara, Yushi
    Yoshikado, Takashi
    Kimura, Miyuki
    Hirota, Takeshi
    Matsuki, Shunji
    Maeda, Kazuya
    Irie, Shin
    Ieiri, Ichiro
    Sugiyama, Yuichi
    Kusuhara, Hiroyuki
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : 78 - 86
  • [10] Structure of human drug transporters OATP1B1 and OATP1B3
    Anca-Denise Ciută
    Kamil Nosol
    Julia Kowal
    Somnath Mukherjee
    Ana S. Ramírez
    Bruno Stieger
    Anthony A. Kossiakoff
    Kaspar P. Locher
    Nature Communications, 14
12345